This study was planned to determine the presence and extent of cardiac
involvement in metabolic storage diseases, including types I and II g
lycogenoses, Gaucher and Neimann-Pick diseases, galactosialidosis and
mucopolysaccharidosis. M-mode, 2-dimensional and Doppler echocardiogra
phic studies were used for the determination of left ventricular wall
thickness, systolic function, anatomic derangement, valvular dysfuncti
on and left ventricular diastolic function in the patient and control
groups. In 19.35% of the cases valvular involvement, and in 59.26% thi
ckening of the left ventricular wall due to metabolic storage, was fou
nd. Left ventricular systolic function was in the normal range. The di
astolic mitral flow patterns of the cases showed obstructive type chan
ges. It can be concluded that in this study, besides previously descri
bed cardiovascular changes, some new findings have been detected by me
ans of echocardiography in patients with metabolic storage diseases.